Pilot study of the cytochrome P450-2D6 genotype in a psychiatric state hospital

American Journal of Psychiatry

Volumn 155, Issue 9, 1998, Pages 1278-1280

  De Leon, Jose ^a   Barnhill, John ^a   Rogers, Thea ^a   Boyle, Jenni ^a   Chou, Wen Hwei ^a   Wedlund, Peter J ^a  

^a Eastern State Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CAUCASIAN; DRUG METABOLISM; ENZYME DEFICIENCY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HOSPITAL; PRIORITY JOURNAL;

EID: 0031695414     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.9.1278     Document Type: Article

References (8)

1. Bertz RJ, Granneman GR: Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin Pharmacokinet 1997; 32:210-258
2. Chen S, Chou W, Blouin R, Mao Z, Meek Q, Neill J, Martin W, Hays L, Wedlund P: Clinical and practical aspects to screening for the cytochrome P450-2D6 (CYP2D6) enzyme polymorphism. Clin Pharmacol Ther 1996; 60:522-534
3. Arthur H, Dahl M, Siwers B, Sjoqvist F: Polymorphic drug metabolism in schizophrenic patients with tardive dyskinesia. J Clin Psychopharmacol 1995; 15:211-216
4. Armstrong M, Daly AK, Blennerhasset R, Ferrier N, Idle JR: Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype. Br J Psychiatry 1997; 170:23-24
5. Agundez J, Ledesma M, Ladero J, Benitez J: Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther 1994; 57:265-269
6. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19
7. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334:1-100
8. Dawson E, Powell JF, Nothen MM, Crocq MA, Lanczik M, Korner J, Rietschel M, van Os J, Wright P, Gill M: An association study of debrisoquine hydroxylase (CYP2D6) polymorphism in schizophrenia. Psychiatr Genet 1994; 4:215-218